Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 271 clinical trials
  • None views
  • None views
  • None views
  • None views
  • None views
  • None views
SeQuent Please Neo Multicenter Registry

The registry evaluates the safety and efficacy of paclitaxel-releasing SeQuent Please Neo balloon in the following scenarios: restenosis, bifurcation lesions, small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The objective is to determine the success of the procedure and the preservation of vascular permeability.

  • 0 views
  • 19 Feb, 2024
Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation

In the past three decades, the burden of stroke has increased in China and has gradually become the leading cause of death. The data acquisition and medical quality management still need to be improved in China. The purpose of this study was to establish online database of acute stroke patients …

acute stroke
stroke
  • 0 views
  • 19 Feb, 2024
Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial brillation can reduce atrial brillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.

  • 0 views
  • 19 Feb, 2024
Systematic Evaluation of Ablation Techniques for Non-Paroxysmal Atrial Fibrillation.

The purpose of this study is to evaluate the safety and effectiveness of empirical posterior wall isolation (PWI), left atrial appendage electrical isolation (LAAEI) and coronary sinus isolation (CSI) when compared to pulmonary vein isolation (PVI) alone: PVI alone, PVI + PWI, PVI + PWI + LAAEI, PVI + PWI …

pulmonary vein isolation
paroxysmal atrial fibrillation
left ventricular dysfunction
chest pain
ablation techniques
  • 0 views
  • 19 Feb, 2024